jueves, 7 de junio de 2018

Funding News | NIH: National Institute of Allergy and Infectious Diseases

Funding News | NIH: National Institute of Allergy and Infectious Diseases

NIAID Logo



June 6, 2018 NIAID Funding News

Feature Articles 

Top Priority for FY 2018 Awards: Update Inclusion Enrollment Records in IMS by June 8

NIH is launching the Human Subjects System (HSS) on June 9, which replaces the Inclusion Management System (IMS). Take one critical step before HSS launches to avoid possible delays for fiscal year 2018 awards.

Opportunities and Resources

Answer NIAID Solicitation for T Cell Immune Epitope Discovery

Gain funding to support large-scale discovery of T cell immune epitopes associated with infectious or autoimmune diseases, commensal organisms, or alloantigens, as well as validation of these epitopes’ role in immune protection or immune-mediated pathogenesis in humans.

New FOA Supports Use of Collaborative Cross Mouse Lines for Immunologic Investigation

Take advantage of an opportunity to introduce a collaborative cross mouse model into your projects to advance understanding of host genes involved in immune regulation and function, and determine whether such models can more faithfully reflect human immune responses.

Respond to Solicitation for the NIAID Virology Quality Assurance Program

Consider sending a proposal to become the next contractor for the NIAID Virology Quality Assurance Program, which provides a comprehensive quality assessment for laboratories performing virologic assays of HIV and other pathogens in clinical trials sponsored by NIAID's Division of AIDS.

In The News

Tell Us About Novel Animal Models for Influenza Research

Investigators, we want to hear about novel or non-traditional animal models that more closely mimic human immune responses to influenza infection or vaccination. These fresh models could aid research to develop a universal flu vaccine.

FDA Versus NIH Clinical Trial Definition: Advice for Applicants

For applications proposing certain types of research, you need to know whether the NIH or FDA definition of a clinical trial takes precedence and if funded whether you should register your clinical trial at—and later submit your summary results information to—ClinicalTrials.gov.

Updates to Investigator-Initiated Clinical Trial U44 Opportunity

NIAID is clarifying the scope of its funding opportunity announcement for small businesses proposing investigator-initiated clinical trials, describing Phase II/IIB and Fast-Track applications and delineating clinical trial planning tasks allowed as part of Fast-Track Phase I Specific Aims and unallowed clinical trial activities.

Share Input on FY 2021-2023 Trans-NIH Strategic Plan for HIV and HIV-Related Research

NIH’s Office of AIDS Research is collecting community feedback to aid development of its FY 2021-2023 Strategic Plan, which will provide information about NIH’s HIV/AIDS research priorities to the scientific community, Congress, community stakeholders, HIV-affected communities, and the broader public.

Advice Corner

Resolve Award Restrictions Indicated by Summary Statement Codes ASAP

Certain codes in your summary statement can indicate an award restriction or bar to award, which block you from funding until you resolve scientific review concerns about human subjects involvement, human subjects inclusion, or animal welfare in your application.

Reader Questions

New Funding Opportunities

See other announcements at Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.

No hay comentarios: